Research
Search
Close
HU Xiaoyong
- Chief Physician, Graduate Supervisor, Associate Professor
- Department: Urology
- Research Area: Surgery (Urology)
- Research Interests: Urinary system tumors and urethral repair and reconstruction
- Contact: huxiaoyong@sjtu.edu.cn
- Chief Physician of Shanghai Sixth People's Hospital, 2022
- MD from Tongji Medical College, 2006
- Teaching Secretary, Department of Urology, Shanghai Sixth People's Hospital
- Member of the Chinese Urological Association
- Zheng K, Sa Y, Hao C, Li C, Li W, Miao F, Gu C, Ding X, Huang J, Zhang Q, Huang J, Song L, Huang J, Si J, Zhang K, Fu Q, Hu X#. Modified Y-V plasty based on MRU evaluation for iatrogenic bladder outlet obliteration: a multicentre experience in China. World J Urol. 2024 Feb 19;42(1):88.
- Zheng K, Hai Y, Xi Y, Zhang Y, Liu Z, Chen W, Hu X#, Zou X, Hao J. Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance. J Transl Med. 2023 Nov 7;21(1):789.
- Zheng K, Gao L, Hao J, Zou X, Hu X#. An immunotherapy response prediction model derived from proliferative CD4+ T cells and antigen-presenting monocytes in ccRCC. Front Immunol. 2022 Aug 25;13:972227.
- Zheng K, Chen S, Hu X#. Peroxisome Proliferator-activated Receptor Gamma Coactivator-1 Alpha: A Double-edged Sword in Prostate Cancer. Curr Cancer Drug Targets. 2022;22(7):541-559.
- Chen J, Wang ZJ, Zhang KL, Xu YJ, Chen ZG, Hu XY#. Selective Castration-resistant Prostate Cancer Photothermal Ablation With Copper Sulfide Nanoplates. Urology. 2019;125:248-255. doi:10.1016/j.urology.2018.11.020
- 01/01/2021-12/31/2023
Shanghai Municipal Health Commission Project, ¥100,000, 202040375
Exploration of Inhibiting Histamine Signal Activation in the Treatment of Advanced Prostate Cancer
Role: Project leader - 01/01/2022-12/31/2023
Open Project of State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, ¥80,000, KF2205
Transrectal targeted injection of fibroin/iron oxide hydrogel magnetocaloric therapy for prostate cancer
Role: Project leader - 07/01/2021-06/30/2023
Wu Jieping Medical Foundation, ¥50,000, 320.6750.2021-17-10
The clinical significance of studying pseudocapsule genes and subcellular structures in renal cell carcinoma
Role: Project leader - 08/01/2015-07/31/2017
Open Project of State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, ¥30,000, LK1524
Near infrared light driven CuS nanomaterial targeted to inhibit castration and resist prostate cancer
Role: Project leader - 01/01/2009-12/31/2011
National Natural Science Foundation Youth Project, ¥230,000, 30801150
Research on Targeted Activation of Omi/HtrA2 Synergy with LASTS/Kpm Stimulating Hormone Refractory Prostate Cancer Cell Apoptosis
Role: Project leader
- [Jie Hao, Xin Zou, Kun Zheng, Xiaoyong Hu] (2023), “A reagent kit for molecular typing detection of prostate cancer”, CN202311069375.9
